Cellyan Biotechnology Co., Ltd (HKPD) · Peers
Cellyan Biotechnology against the 10 other companies here in its SEC industry, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 11, highest first.
Measure by measure
| Measure | HKPD | Peer median | Rank |
|---|---|---|---|
| Market value | $4.65M | median $141.77M | 9 of 11 |
| EV/EBITDA | 35.8× | median 16.8× | 1 of 6 |
| P/S | 0.2× | median 0.3× | 8 of 11 |
| FCF yield | 10.7% | median 4.9% | 3 of 11 |
| Gross margin | 11.9% | median 7.1% | 5 of 11 |
| Operating margin | 0.6% | median -12.8% | 5 of 11 |
| Net margin | -0.1% | median -24.4% | 5 of 11 |
| ROIC | 1.4% | median 9.1% | 5 of 9 |
| ROE | -0.5% | median -68.4% | 2 of 5 |
| Net debt / EBITDA | 12.3× | median 1.1× | 1 of 6 |
| Current ratio | 3.5× | median 0.9× | 1 of 11 |
| Stock pay / revenue | 0.0% | median 2.0% | 11 of 11 |
| Share count change | 38.6% | median 2.0% | 5 of 10 |
Green where Cellyan Biotechnology is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| HKPDCellyan Biotechnology Co., Ltd | $4.65M | P/E – | 1.4% | 4.8 |
| MCKMcKesson Corporation | $117.15B | P/E 25.5× | 998.3% | 6.0 |
| CORCencora, Inc. | $65.06B | P/E 41.9× | 19.6% | 5.1 |
| CAHCardinal Health Inc | $59.09B | P/E 34.5× | 218.0% | 5.9 |
| HLFHerbalife Ltd. | $1.53B | P/E 9.3× | 32.8% | 5.7 |
| NUSNU Skin Enterprises, Inc. | $250.20M | P/E – | -1.4% | 4.7 |
| COSMCosmos Health Inc. | $33.34M | P/E – | -65.7% | 4.0 |
| HWHHWH International Inc. | $20.71M | P/E – | -204.9% | 2.8 |
| MEDSDataMeds AI, Inc. | $8.05M | P/E – | -191.1% | 2.0 |
| NASCCan B Corp | $981,536 | P/E – | – | 3.3 |
| STEKStemtech Corp | $299,703 | P/E – | – | 3.1 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.